Status:
RECRUITING
Clinical Prediction Model for In-Hospital Rebleeding in Acute Non-Variceal Upper Gastrointestinal Bleeding
Lead Sponsor:
Junwei Yan
Conditions:
Acute Non-variceal Upper Gastrointestinal Bleeding
Eligibility:
All Genders
18+ years
Brief Summary
ANVUGIB is a serious condition that can cause symptoms like vomiting blood or passing black stools. Although treatments have improved, about 10% to 30% of patients experience rebleeding shortly after ...
Eligibility Criteria
Inclusion Criteria:
- age exceeding 18 years,
- Clinical diagnosis of Acute Non-Variceal Upper Gastrointestinal Bleeding ,
- patients who underwent endoscopy within 24 hours of admission with confirmation of non-variceal bleeding
Exclusion Criteria:
- Upper Gastrointestinal Bleeding during hospitalization;
- transfer from other hospitals;
- variceal bleeding;
- lower gastrointestinal bleeding.;
- bleeding attributed to systemic diseases like disseminated intravascular coagulation (DIC) and hematological disorders;
- patients with incomplete clinical data or laboratory test results;
- patients who either requested early discharge or declined gastroscopy.
Key Trial Info
Start Date :
November 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06697691
Start Date
November 22 2024
End Date
December 1 2024
Last Update
November 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Central Hospital of Wuhan
Wuhan, Hubei, China, 430000